Management of recurrent ovarian carcinoma.
Ang
P T
PT
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Kavanagh
J
J
D002288:Adenocarcinoma, Mucinous / Q000556:secondary* / Q000628:therapy; D000368:Aged; D006585:Altretamine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007813:Laparotomy; D010051:Ovarian Neoplasms / Q000628:therapy; D012086:Reoperation
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D006585:Altretamine